The Prison Economy of Needles and Syringes: What Opportunities Exist for Blood Borne Virus Risk Reduction When Prices Are so High?

Abstract

AimA formal Needle and Syringe Program (NSP) is not provided in Australian prisons. Injecting equipment circulates in prisons as part of an informal and illegal economy. This paper examined how this economy generates blood-borne virus (BBV) risk and risk mitigation opportunities for inmates.MethodThe HITS-p cohort recruited New South Wales inmates who had reported ever injecting drugs and who had a negative HCV serological test within 12 months prior to enrolment. For this study, qualitative interviews were conducted with 30 participants enrolled in HITS-p. Participants included 10 women and were incarcerated in 12 prisons.ResultsA needle/syringe was nominated as being typically priced in the ‘inside’ prison economy at $100-$150, with a range of $50-$350. Purchase or hire of equipment was paid for in cash (including transactions that occurred outside prison) and in exchange for drugs and other commodities. A range of other resources was required to enable successful needle/syringe economies, especially relationships with visitors and other prisoners, and violence to ensure payment of debts. Strategies to mitigate BBV risk included retaining one needle/syringe for personal use while hiring out others, keeping drug use (and ownership of equipment) “quiet”, stealing used equipment from the prison health clinic, and manufacture of syringes from other items available in the prison.ConclusionsThe provision of prison NSP would disrupt the inside economies built around contraband needles/syringes, as well as minimise BBV risk. However, any model of prison NSP should be interrogated for any unanticipated markets that could be generated as a result of its regulatory practices.

Is Tattooing a Risk Factor for Hepatitis C Transmission?: An Updated Systematic Review and Meta-Analysis

“…Previous studies from Australia, the United States, and Europe indicated that the prevalence of hepatitis C infection in prisons ranges from 8% to 57% (62)(63)(64)(65). High risk behaviors as common habits including needle sharing and reusing tattoo needles and equipment were reported 45% among prisoners (45,66). However, a few prisons worldwide provide sterile needles and syringes for inmates (67)(68)(69), which is a measure unlikely to be adopted by most pris-Hepat Mon.…”

‘It's just basically a box full of disease’—navigating sterile syringe scarcity in a rural New England state

“…For those without transportation, we documented injection practices that sometimes more closely resembled carceral than community injection. Stockpiling syringe parts, doctoring broken syringes and creating new syringes out of bits of plastic and metal have all been reported in studies of injection in prison [65–67], where syringe distribution is prohibited. Similarly, our participants reported high levels of both syringe sharing and re‐use; along with obtaining used syringes from peers, from the ground and/or from biohazard containers, this put them at high risk of both viral and bacterial infections.…”

The discourses of risk of drug users in prison

“…As regards the NEP, the “prudent” users, despite rejecting intravenous drug use, consider this option to be a good one to prevent infection with blood-borne diseases. The “reckless users” reject the programme in order to avoid institutional control, although they use ruses to get syringes from other users, which involves the risk of transmission of diseases, as noted in the study by Treloar et al, carried out in Australian prisons 30 . For their part, the “adventurous” users recognise the benefits of the NEP, but demand a number of reforms to increase the programme’s effectiveness, as demonstrated in several studies: improving access and the criteria for dispensation to increase coverage 7 , 31 ; increasing the number of syringes in the dispensation 32 ; and withdrawing retractable syringes and replacing them with others that are more adaptable to user practices 33 , 34 .…”